NCT07041606

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

RecruitingOBSERVATIONAL

Trial Details

Start: 2025-06-24Est. Completion: 2027-06-30

Enrollment target: 500 participants

Locations

Research Site, Arkhangelsk, Russia
Research Site, Barnaul, Russia
Research Site, Chelyabinsk, Russia
Research Site, Irkutsk, Russia
Research Site, Izhevsk, Russia
Research Site, Krasnodar, Russia
Research Site, Krasnoyarsk, Russia
Research Site, Lyubertsy, Russia
Research Site, Moscow, Russia
Research Site, Moscow, Russia
Research Site, Murmansk, Russia
Research Site, Obninsk, Russia
Research Site, Saint Petersburg, Russia
Research Site, Severodvinsk, Russia
Research Site, Sochi, Russia
Research Site, Tomsk, Russia
Research Site, Tver', Russia
Research Site, Ufa, Russia
Research Site, Vladivostok, Russia
Research Site, Yaroslavl, Russia
Research Site, Yekaterinburg, Russia

Other microbiome trials you might be interested in

SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial CancerPhase 4Recruiting

Endometrial CancerEndometrial Cancer Stage IAtypical Endometrial Hyperplasia and Endometrial Carcinoma Stage IAtypical Endometrial HyperplasiaEndometrial Intraepithelial NeoplasiaObesity & OverweightBMI>40ObesityObesity Grade III

SHAPE-ENDO is a single-center, open-label, pilot randomized clinical trial conducted at Hospital Universitari de Bellvit…

Multiple LocationsEst. completion Apr 2031

View Trial →

Laparotomy vs Laparoscopy in Endometrial Cancer StagingRecruiting

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.